New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2013
12:00 EDTRMBSRambus rises 16.4%
Rambus is up 16.4%, or $1.40, to $9.92
News For RMBS From The Last 14 Days
Check below for free stories on RMBS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2014
10:02 EDTRMBSRambus falls after earnings and guidance, levels to watch
Subscribe for More Information
09:00 EDTRMBSRambus falls 7.3%
Subscribe for More Information
April 21, 2014
19:02 EDTRMBSOn The Fly: After Hours Movers
NOTABLE: Allergan (AGN), up 20%, and Valeant Pharmaceuticals (VRX), up 9.1%, both advanced after The Wall Street Journal reported that activist investor Bill Ackman is teaming up with Valeant to make a bid for Allergan. Following the report, Ackman's Pershing Square filed a 13D with the SEC disclosing a 9.7% stake in Allergan and outlining an agreement with Valeant. The agreement, among other things, said that Valeant plans to make a bid for Allergan comprised of $15B of cash and a to-be-determined amount of Valeant stock. The filing also showed that Ackman began building a position in Allergan in late February, and at that time entered an agreement with Valeant forming a new, jointly-owned entity through which to acquire a position in Allergan. CNBC's David Faber reported that Valeant is expected to officially make a hostile bid for Allergan by tomorrow. UP AFTER EARNINGS: Netflix (NFLX) gained 6.3% after reporting profits that beat expectations on revenues that were in-line with expectations. The streaming internet video service also reported that U.S. subscribers grew by 2.25M in the first quarter, with its international subscriber base expanding by 1.75M for the period. DOWN AFTER EARNINGS: Rambus (RMBS) fell 7.5% after providing a second quarter revenue outlook that fell short of expectations, with the company adding that its revenue outlook, "includes expectations that the company will sign new customers for patent as well as solutions licensing." Rambus' first quarter results, however, came in better than expected, and the company also reaffirmed its fiscal 2014 revenue outlook.
17:21 EDTRMBSRambus reaffirms FY14 revenue $295M-$305M, consensus $298.75M
Subscribe for More Information
16:49 EDTRMBSRambus lower by 10% after providing Q2 revenue guidance
Subscribe for More Information
16:12 EDTRMBSRambus sees Q2 revenue $69M-$74M, consensus $74.48M
16:11 EDTRMBSRambus reports Q1 adjusted EPS 17c, consensus 3c
Subscribe for More Information
15:16 EDTRMBSNotable companies reporting after market close
Subscribe for More Information
April 11, 2014
06:58 EDTRMBSRambus initiated with a Buy at Benchmark Co.
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use